Barclays’s VanEck ChiNext Innovators ETF CNXT Stock Holding History

Barclays’s Portfolio CNXT Stock Details CNXT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-120	Closed	-$5.3K	–	5307
2025 Q3	$5.3K	Buy	+120	New	+$4.21K	﹤0.01%	5079
2021 Q3	–	Sell	-284	Closed	-$15K	–	4768
2021 Q2	$15K	Buy	+284	New	+$14K	﹤0.01%	4552

Other funds holding CNXT

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Barclays's CNXT Position: Q4 2025 in Review

Barclays sold out of VanEck ChiNext Innovators ETF (CNXT) in Q4 2025, closing a stake of 120 shares — an estimated $5.3K sold.

Barclays first reported a position in CNXT in Q2 2021 and held it in 2 quarters. The position peaked at $15K in Q2 2021. 13 funds tracked by Wall St. Rank hold CNXT as of Q4 2025.

Barclays reported no remaining VanEck ChiNext Innovators ETF position as of Q4 2025 after selling out during the quarter.
Barclays sold 120 VanEck ChiNext Innovators ETF shares in Q4 2025, an estimated $5.3K.
Barclays first reported a position in VanEck ChiNext Innovators ETF in Q2 2021 and held it in 2 quarters.
Barclays's VanEck ChiNext Innovators ETF position peaked at $15K in Q2 2021.
13 funds tracked by Wall St. Rank held VanEck ChiNext Innovators ETF as of Q4 2025.

Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.